|
 |
 |
Comments
Did you read today's front page stories & breaking news?
SYS-CON.TV
|
From the Wires
Radius Health to Present at BIO CEO & Investor in New York
By: Marketwired .
Feb. 8, 2013 12:38 PM
CAMBRIDGE, MA -- (Marketwire) -- 02/08/13 -- Radius Health, Inc. ("Radius"), a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women's health conditions, announced today that it will present at the 15th annual BIO CEO & Investor Conference in New York, NY. Michael Wyzga, President and CEO of Radius Health, is scheduled to present on Monday, Feb. 11, at 2:15 p.m. (EST). Radius will provide an update on the company and its Phase 3 asset, BA058, a novel anabolic, bone-building compound under development as a potential treatment for postmenopausal women with osteoporosis at high risk for fracture. BA058-SC, an injectable form of BA058, is currently in a Phase 3 trial, and BA058-TD, is in a Phase 2 trial studying the efficacy of delivering BA058 via transdermal patch. Radius and 3M Drug Delivery Systems have an exclusive partnership agreement for development and commercialization of BA058-TD.
Event BIO CEO & Investor The Radius presentation will be available one hour after the presentation via a webcast here: http://www.veracast.com/webcasts/bio/ceoinvestor2013/37119700.cfm
About Radius Health CONTACTS:
Latest AJAXWorld RIA Stories
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
|
SYS-CON Featured Whitepapers
Most Read This Week
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
| | | | | | | | |
|
|
|
|
|
|
| | | | | | | | | | | | | | | | | | | | | | | | | | |
|
|
| SYS-CON MEDIA: | | | | |
| SYS-CON EVENTS: | | | | | |
| INTERNATIONAL SITES: | | | | | | | | | | |
 |
Terms of Use & Our Privacy Statement  About Newsfeeds / Video Feeds |
| Copyright ©1994-2008 SYS-CON Publications, Inc. All Rights Reserved. All marks are trademarks of SYS-CON Media. |
| Reproduction in whole or in part in any form or medium without express written permission of SYS-CON Publications, Inc. is prohibited. |
.gif)
In Part IV, we wrapped up our discussions on bandwidth, congestion and packet loss. In Part V, we examine the four types of processing delays visible on the network, using the request/reply paradigm we outlined in Part I.
From the network’s perspective, we allocate the time peri...
In Part II, we discussed performance constraints caused by both bandwidth and congestion. Purposely omitted was a discussion about packet loss – which is often an inevitable result of heavy network congestion. I’ll use this blog entry on TCP slow-start to introduce the Congestion...
Compuware Corporation has announced that SD Times Magazine has named Compuware APM to its 2014 SD Times 100 list as a leader and innovator in the "Mobile Testing, Quality Assurance, and Security" category. The award reaffirms the company's ongoing success to driving mobile applic...
When we think of application performance problems that are network-related, we often immediately think of bandwidth and congestion as likely culprits; faster speeds and less traffic will solve everything, right? This is reminiscent of recent ISP wars; which is better, DSL or cabl...
As a network professional, one of your newer roles is likely troubleshooting poor application performance. For most of us, our jobs have advanced beyond network “health,” towards sharing – if not owning – responsibility for application delivery. There are many reasons for this mo...
